Nilutamide: possible utility as a second-line hormonal agent
- 1 December 2001
- Vol. 58 (6) , 1016-1020
- https://doi.org/10.1016/s0090-4295(01)01455-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCERJournal of Urology, 2000
- Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trialsThe Lancet, 2000
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999
- NILUTAMIDE RESPONSE AFTER FLUTAMIDE FAILURE IN POST-ORCHIECTOMY PROGRESSIVE PROSTATE CANCERJournal of Urology, 1998
- Prostate Specific Antigen Decreases After Withdrawal of Antiandrogen Therapy with Bicalutamide or Flutamide in Patients Receiving Combined Androgen BlockadeJournal of Urology, 1997
- Ketoconazole Retains Activity in Advanced Prostate Cancer Patients with Progression Despite Flutamide WithdrawalJournal of Urology, 1997
- Antiandrogen Withdrawal Syndrome With NilutamideJournal of Urology, 1997
- Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate CancerNew England Journal of Medicine, 1995
- STUDIES ON PROSTATIC CANCERArchives of Surgery, 1941